Trademark: 97065557
Word
SYNAPSE MED
Status Date
Wednesday, June 12, 2024
Filing Date
Friday, October 8, 2021
Published for Opposition
Tuesday, July 16, 2024
9 Downloadable computer software using artificial intelligence for medical prescription assistance, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence to avoid medical risks and contraindications and for drug interaction prevention, namely, software for word processing and establishing standardized directories; Downloadable computer software using artificial intelligence for medical prescriptions analysis, namely, software for word processing and establishing standardized directories; none of the above products are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field
44 Telemedicine services; Prescription assistance modules in the nature of providing information in the field of medical prescriptions via telemedicine platforms; Providing advice relating to medical services provided via telecommunications technology; providing information in the field of telemedicine; providing information in the field of medical prescription; providing information in the field of medical prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field
42 Research in the field of artificial intelligence for computer software design for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Research in the field of artificial intelligence for computer software design for prescription analysis; Software design and development for medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software design and development for prescription analysis; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories in the fields of medical prescription assistance, for the prevention of medicinal risks, contraindications and drug interactions; Software as a service (SAAS) services featuring software using artificial intelligence for word processing and establishing standardized directories for prescription analysis; none of the above services are for use or provided in the field of medical informatics management and image recognition, or AI platforms in the medical field; Software as a service (SAAS) services featuring software modules for providing prescription assistance through telemedicine platforms
The mark consists of the wording "SYNAPSE" in blue with the wording "MED" in blue superscripted to the right of the "E" in "SYNAPSE".
The color(s) blue is/are claimed as a feature of the mark.
"MED"
Oct 12, 2021
New Application Entered
Nov 1, 2021
New Application Office Supplied Data Entered
Jul 13, 2022
Assigned To Examiner
Jul 14, 2022
Non-Final Action Written
Jul 14, 2022
Non-Final Action E-Mailed
Jul 14, 2022
Notification Of Non-Final Action E-Mailed
Jan 16, 2023
Teas Response To Office Action Received
Jan 16, 2023
Correspondence Received In Law Office
Jan 17, 2023
Teas/Email Correspondence Entered
Feb 16, 2023
Suspension Letter Written
Feb 16, 2023
Letter Of Suspension E-Mailed
Feb 16, 2023
Notification Of Letter Of Suspension E-Mailed
Sep 14, 2023
Suspension Inquiry Written
Sep 14, 2023
Inquiry To Suspension E-Mailed
Sep 14, 2023
Notification Of Inquiry As To Suspension E-Mailed
Dec 14, 2023
Teas Response To Suspension Inquiry Received
Apr 17, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 17, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 6, 2024
Assigned To Lie
May 6, 2024
Correspondence Received In Law Office
May 6, 2024
Teas/Email Correspondence Entered
Apr 17, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 17, 2024
Teas Change Of Owner Address Received
Apr 17, 2024
Teas Change Of Correspondence Received
Apr 17, 2024
Teas Change Of Domestic Representatives Address
Jun 7, 2024
Examiners Amendment E-Mailed
Jun 7, 2024
Examiners Amendment -Written
Jun 7, 2024
Notification Of Examiners Amendment E-Mailed
Jun 7, 2024
Examiner's Amendment Entered
Jun 11, 2024
Approved For Pub - Principal Register
Jun 26, 2024
Notification Of Notice Of Publication E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
